c-Kit expression in desmoid fibromatosis: Comparative immunohistochemical evaluation of two commercial antibodies

American Journal of Clinical Pathology

Volumn 119, Issue 3, 2003, Pages 339-345

  Lucas, David R ^a,b   Al Abbadi, Mousa ^a   Tabaczka, Pamela ^a   Hamre, Merlin R ^a   Weaver, Donald W ^a   Mott, Michael J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

C Kit; Desmoid fibromatosis; Gastrointestinal stromal tumor; Gleevec; Imatinib mesylate; Immunohistochemistry; Soft tissue neoplasms; STI571; Tyrosine kinase receptor

Indexed keywords

BIOLOGICAL MARKER; BUFFER; CITRIC ACID; IMATINIB; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY A4502; POLYCLONAL ANTIBODY C 19; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; TUMOR ANTIGEN;

ANTIGEN RETRIEVAL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DESMOID FIBROMATOSIS; DESMOID TUMOR; DILUTION; DRUG EFFECT; ENDOTHELIUM; EVALUATION; FIBROMATOSIS; HEATING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; REPRODUCIBILITY; SKELETAL MUSCLE; SMOOTH MUSCLE; STROMA; TECHNIQUE; TISSUE FIXATION; ANIMAL; CELL COUNT; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATHOLOGY; RABBIT;

ANIMALS; ANTIGENS, NEOPLASM; CELL COUNT; FIBROMATOSIS, AGGRESSIVE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-KIT; RABBITS;

EID: 0037365824     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AN4E2ETCJ4R6JJUY     Document Type: Article

References (22)

1. Bus PJ, Verspaget HW, van Krieken JH, et al. Treatment of mesenteric desmoid tumours with the anti-oestrogenic agent toremifene: case histories and an overview of the literature. Eur J Gastroenterol Hepatol. 1999;10:1179-1183.
2. Kinzbrunner B, Ritter S, Domingo J, et al. Remission of rapidly growing desmoid tumors after tamoxifen therapy. Cancer. 1983;52:2201-2204.
3. Leithner A, Schnack B, Kayyerschafka T, et al. Treatment of extra-abdominal desmoid tumors with interferon-alpha with or without tretinoin. J Surg Oncol. 2000;73:21-25.
4. Patel SR, Evans HL, Benjamin RS. Combination chemotherapy in adult desmoid tumors. Cancer. 1993;72:3244-3247.
5. Skapek SX, Hawk BJ, Hoffer FA, et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid in children. J Clin Oncol. 1998;16:3021-3027.
6. Yantiss RK, Spiro IJ, Compton CC, et al. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol. 2000;24:947-957.
7. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GlSTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13:1134-1142.
8. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188-193.
9. Miettinen M. Are desmoid tumors KIT positive [letter]? Am J Surg Pathol. 2001;25:549-550.
10. Heinrich MC, Blanke CD, Druker BJ, et al. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol. 2002;20:1692-1703.
11. Kindblom L-G, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of interstitial cells of Cajal. Am J Pathol. 1998;152:1259-1269.
12. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular study of 44 cases. Am J Surg Pathol. 2000;24:1339-1352.
13. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728-734.
14. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissue: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29:498-504.
15. Lammie A, Drobnjak M, Gerald W. Expression of c-kit and kit ligand in normal human tissues. J Histochem Cytochem. 1994;42:1417-1425.
16. Matsuda R, Takahashi T, Nakamura S, et al. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol. 1993;142:339-346.
17. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch. 1994;424:135-141.
18. Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stroma tumors. Am J Surg Pathol. 1999;23:377-389.
19. Alman BA, Naber SP, Terek RM, et al. Platelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell cultures. J Orthop Res. 1995;13:67-77.
20. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol. 2001;25:1204-1207.
21. Wick MR, Mills SE. Consensual interpretive guidelines for diagnostic immunohistochemistry. Am J Surg Pathol. 2001;25:1208-1210.
22. Smithey BE, Pappo AS, Hill, DA. c-Kit expression in pediatric solid tumors: a comparative immunohistochemical study. Am J Surg Pathol. 2002;26:486-492.